RCKT FY 2019 Earnings — Rocket Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

RCKTRocket Pharmaceuticals, Inc.

$538M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$426,000

Operating Income

-$76M

Net Income

-$83M

EPS (Diluted)

$-1.70

Cash Flow

Operating Cash Flow

-$65M

Free Cash Flow

-$88M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$372M

Total Liabilities

$65M

Stockholders' Equity

$307M

Cash & Equivalents

$185M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$426,000	-$330,000	-29.1%
Operating Income	-$76M	-$71M	-7.0%
Net Income	-$83M	-$75M	-11.7%